AAAAAA
Results: 1-25/29
Authors:
HUANG Y
NUSSBAUM N
JAFFA AA
LOPESVIRELLA MF
Citation: Y. Huang et al., OXIDIZED LDL-CONTAINING IMMUNE-COMPLEXES STIMULATE MITOGEN-ACTIVATED PROTEIN (MAP) KINASE IN MACROPHAGES, Journal of investigative medicine, 46(3), 1998, pp. 232-232
Authors:
KOSKINEN S
ENOCKSON C
LOPESVIRELLA MF
VIRELLA G
Citation: S. Koskinen et al., PREPARATION OF A HUMAN STANDARD FOR DETERMINATION OF THE LEVELS OF ANTIBODIES TO OXIDATIVELY MODIFIED LOW-DENSITY LIPOPROTEINS, Clinical and diagnostic laboratory immunology (Print), 5(6), 1998, pp. 817-822
Authors:
TAKEI A
HUANG Y
LOPESVIRELLA MF
Citation: A. Takei et al., INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) EXPRESSION INDUCED BY OXLDL ON HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS (HUVEC) DEPENDS ON THE STAGE OF LDL OXIDATION, Diabetes, 47, 1998, pp. 453-453
Authors:
KOSKINEN S
LOPESVIRELLA MF
VIRELLA G
Citation: S. Koskinen et al., STANDARDIZATION OF AN ENZYMOIMMUNOASSAY FOR MEASUREMENT OF ANTI-OXLDLANTIBODIES, Diabetes, 47, 1998, pp. 1410-1410
Authors:
HUANG Y
MIRONOVA M
LOPESVIRELLA MF
Citation: Y. Huang et al., OXIDIZED LOW-DENSITY-LIPOPROTEIN STIMULATES MATRIX METALLOPROTEINASE-1 IN HUMAN VASCULAR ENDOTHELIAL-CELLS, Circulation, 98(17), 1998, pp. 4268-4268
Authors:
MIRONOVA M
VIRELLA G
LOPESVIRELLA MF
Citation: M. Mironova et al., ISOLATION AND CHARACTERIZATION OF HUMAN ANTIOXIDIZED LDL AUTOANTIBODIES (VOL 16, PG 222, 1996), Arteriosclerosis, thrombosis, and vascular biology, 17(10), 1997, pp. 2306-2306
Authors:
LOPESVIRELLA MF
MIRONOVA M
VIRELLA G
Citation: Mf. Lopesvirella et al., LDL-CONTAINING IMMUNE-COMPLEXES AND ATHEROSCLEROSIS IN DIABETES, Diabetes reviews, 5(4), 1997, pp. 410-424
Authors:
VIRELLA G
MIRONOVA M
VIRELLA I
LOPESVIRELLA MF
Citation: G. Virella et al., THE ATHEROGENIC POTENTIAL OF ANTI-LDL ANTIBODIES, Journal of allergy and clinical immunology, 99(1), 1997, pp. 92-92
Authors:
MIRONOVA M
VIRELLA G
VIRELLALOWELL I
LOPESVIRELLA MF
Citation: M. Mironova et al., ANTI-MODIFIED LDL ANTIBODIES AND LDL-CONTAINING IMMUNE-COMPLEXES IN IDDM PATIENTS AND HEALTHY CONTROLS, Clinical immunology and immunopathology, 85(1), 1997, pp. 73-82
Authors:
HUANG Y
GHOSH MJ
LOPESVIRELLA MF
Citation: Y. Huang et al., TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL REGULATION OF LDL RECEPTOR GENE-EXPRESSION IN PMA-TREATED THP-1 CELLS BY LDL-CONTAINING IMMUNE-COMPLEXES, Journal of lipid research, 38(1), 1997, pp. 110-120
Authors:
LOPESVIRELLA MF
BINZAFAR N
RACKLEY S
TAKEI A
LAVIA M
VIRELLA G
Citation: Mf. Lopesvirella et al., THE UPTAKE OF LDL-IC BY HUMAN MACROPHAGES - PREDOMINANT INVOLVEMENT OF THE FC-GAMMA-RI RECEPTOR, Atherosclerosis, 135(2), 1997, pp. 161-170
Authors:
MIRONOVA M
VIRELLA G
LOPESVIRELLA MF
Citation: M. Mironova et al., ISOLATION AND CHARACTERIZATION OF HUMAN ANTIOXIDIZED LDL AUTOANTIBODIES, Arteriosclerosis, thrombosis, and vascular biology, 16(2), 1996, pp. 222-229
Authors:
LOPESVIRELLA MF
VIRELLA G
Citation: Mf. Lopesvirella et G. Virella, MODIFIED LIPOPROTEINS, CYTOKINES AND MACROVASCULAR DISEASE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Annals of medicine, 28(4), 1996, pp. 347-354
Authors:
LOPESVIRELLA MF
KLEIN RL
VIRELLA G
Citation: Mf. Lopesvirella et al., MODIFICATION OF LIPOPROTEINS IN DIABETES, Diabetes/metabolism reviews, 12(1), 1996, pp. 69-90
Authors:
JENKINS AJ
KLEIN RL
CHASSEREAU CN
HERMAYER KL
LOPESVIRELLA MF
Citation: Aj. Jenkins et al., LDL FROM PATIENTS WITH WELL-CONTROLLED IDDM IS NOT MORE SUSCEPTIBLE TO IN-VITRO OXIDATION, Diabetes, 45(6), 1996, pp. 762-767
Authors:
LOPESVIRELLA MF
VIRELLA G
Citation: Mf. Lopesvirella et G. Virella, CYTOKINES, MODIFIED LIPOPROTEINS, AND ARTERIOSCLEROSIS IN DIABETES, Diabetes, 45, 1996, pp. 40-44
Authors:
MIRONOVA M
VIRELLA G
VIRELLALOWELL I
LOPESVIRELLA MF
Citation: M. Mironova et al., CHOLESTERYL ESTER ACCUMULATION IN MACROPHAGES EXPOSED TO LDL-IMMUNE COMPLEXES ISOLATED FROM DIABETIC AND CONTROL SUBJECTS, Diabetes, 45, 1996, pp. 995-995
Authors:
JOKI R
KLEIN RL
LOPESVIRELLA MF
COLWELL JA
Citation: R. Joki et al., RELEASE OF PLATELET PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN WHOLE-BLOOD IS INCREASED IN PATIENTS WITH TYPE-II DIABETES, Diabetes care, 18(8), 1995, pp. 1150-1155
Authors:
VIRELLA G
MUNOZ JF
GALBRAITH GMP
GISSINGER C
CHASSEREAU C
LOPESVIRELLA MF
Citation: G. Virella et al., ACTIVATION OF HUMAN MONOCYTE-DERIVED MACROPHAGES BY IMMUNE-COMPLEXES CONTAINING LOW-DENSITY-LIPOPROTEIN, Clinical immunology and immunopathology, 75(2), 1995, pp. 179-189
Authors:
KLEIN RL
LAIMINS M
LOPESVIRELLA MF
Citation: Rl. Klein et al., ISOLATION, CHARACTERIZATION, AND METABOLISM OF THE GLYCATED AND NONGLYCATED SUBFRACTIONS OF LOW-DENSITY LIPOPROTEINS ISOLATED FROM TYPE-I DIABETIC-PATIENTS AND NONDIABETIC SUBJECTS, Diabetes, 44(9), 1995, pp. 1093-1098
Authors:
VIRELLA G
MIRONOVA M
LOPESVIRELLA MF
Citation: G. Virella et al., COMPARING ASSAYS OF ANTIBODIES TO MODIFIED LOW-DENSITY LIPOPROTEINS, Clinical chemistry, 41(2), 1995, pp. 324-325
Authors:
JOKL R
LAIMINS M
KLEIN RL
LYONS TJ
LOPESVIRELLA MF
COLWELL JA
Citation: R. Jokl et al., PLATELET PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN PATIENTS WITH TYPE-II DIABETES, Diabetes care, 17(8), 1994, pp. 818-823
Authors:
LOPESVIRELLA MF
VIRELLA G
Citation: Mf. Lopesvirella et G. Virella, ATHEROSCLEROSIS AND AUTOIMMUNITY, Clinical immunology and immunopathology, 73(2), 1994, pp. 155-167
Authors:
LOPESVIRELLA MF
CARTER TD
CUTTER GR
HOGAN EL
GAINES KJ
Citation: Mf. Lopesvirella et al., RACE AND GENDER-DIFFERENCES OF LIPID LIPOPROTEINS IN STROKE PATIENTS - SECORDS STUDY, Circulation, 90(4), 1994, pp. 399-399
Authors:
LOPESVIRELLA MF
CARTER TD
CUTTER GR
HOGAN EL
GAINES KJ
Citation: Mf. Lopesvirella et al., RACE AND GENDER-DIFFERENCES OF LIPID LIPOPROTEINS IN STROKE PATIENTS - SECORDS STUDY, Circulation, 90(4), 1994, pp. 399-399